# COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR

> **NCT04599959** · NA · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 151 (actual)

## Conditions studied

- Covid-19

## Interventions

- **DIAGNOSTIC_TEST:** Sampling of SARS-CoV-2 RNA from nasopharyngeal swab specimen or saliva collected via Salivette Cortisol

## Key facts

- **NCT ID:** NCT04599959
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-26
- **Primary completion:** 2021-01-20
- **Final completion:** 2021-01-20
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2021-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04599959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04599959, "COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04599959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*